EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis

Yoshiki Katada iD, Shunsaku Nakagawa, Miki Nagao, Keisuke Umemura iD, Kotaro Itohara iD, Asami Nishikawa, Sachiyo Hashi, Yurie Katsube, Daiki Hira, Akihiro Ohsumi, Daisuke Nakajima, Hiroshi Date und 1 weitere

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14141 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Yoshiki Katada und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Leukopenia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japanese Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Valganciclovir is the first‐line agent for Cytomegalovirus prophylaxis after lung transplantation. However, its use is associated with a relatively high risk of hematological toxicity. This study aimed to investigate the relationship between trough ganciclovir concentration and hematologic toxicity in lung transplantation patients receiving valganciclovir prophylaxis, and identify factors that affect ganciclovir pharmacokinetics in this population.

Methods

This prospective observational study included 24 lung transplant patients receiving valganciclovir prophylaxis. The cutoff value of trough ganciclovir concentration was estimated using receiver operating characteristic analysis in leukopenia grade 3 and higher. Population pharmacokinetic analysis was performed using a nonlinear mixed‐effects modeling program.

Results

The trough ganciclovir concentration was significantly higher in the group with leukopenia grades 3 or higher than in the group with grades less than or equal to 2 (1605.7 ± 860.1 ng/mL [ n = 3] vs. 380.5 ± 175.8 ng/mL ( n = 21), p < .001). The cutoff value of trough ganciclovir concentration for predicting greater than or equal to grade 3 leukopenia was estimated as 872.0 ng/mL. Creatinine clearance and lung re‐transplantation were found to have a significant impact on the total body clearance of valganciclovir. Ganciclovir clearance was decreased in patients with reduced creatine clearance or re‐transplantation.

Conclusion

These results suggest that higher ganciclovir trough concentrations are associated with an increased risk of leukopenia grade 3 or higher, and that creatinine clearance and lung re‐transplantation affected the pharmacokinetics of ganciclovir. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsLeukopeniaHumansGanciclovirValganciclovirAntiviral AgentsTransplant RecipientsCreatinineLung

Stichwörter der Autor:innen

Cytomegalovirusganciclovirlung transplantationprophylaxistherapeutic drug monitoringvalganciclovir

Substanzen

GanciclovirValganciclovirAntiviral AgentsCreatinine

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
  • Department of Infection Control and Prevention, Kyoto University Hospital, Sakyo-ku, Kyoto, Japan.
  • Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
  • Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

ORCID-Profile: Yoshiki Katada, Keisuke Umemura, Kotaro Itohara

Förderung

  • Japanese Society for the Promotion of Science

Zitieren

APA

Katada, Y., Nakagawa, S., Nagao, M., Umemura, K., Itohara, K., Nishikawa, A., Hashi, S., Katsube, Y., Hira, D., Ohsumi, A., Nakajima, D., Date, H., & Terada, T. (2023). Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis. Transplant Infectious Disease. https://doi.org/10.1111/tid.14141

Vancouver

Katada Y, Nakagawa S, Nagao M, Umemura K, Itohara K, Nishikawa A, et al. Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis. Transplant Infectious Disease. 2023. doi:10.1111/tid.14141

BibTeX
@article{Katada2023,
  author = {Katada, Yoshiki and Nakagawa, Shunsaku and Nagao, Miki and Umemura, Keisuke and Itohara, Kotaro and Nishikawa, Asami and Hashi, Sachiyo and Katsube, Yurie and Hira, Daiki and Ohsumi, Akihiro and Nakajima, Daisuke and Date, Hiroshi and Terada, Tomohiro},
  title = {Trough ganciclovir concentration as predictor of leukopenia in lung transplant recipients receiving valganciclovir prophylaxis},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14141}
}
Kostenlos starten →